Shares of Diaceutics PLC (LON:DXRX - Get Free Report) rose 0.4% during trading on Tuesday . The company traded as high as GBX 120 ($1.59) and last traded at GBX 118 ($1.57). Approximately 23,993 shares traded hands during mid-day trading, a decline of 76% from the average daily volume of 99,987 shares. The stock had previously closed at GBX 117.50 ($1.56).
Diaceutics Price Performance
The business has a 50-day moving average of GBX 123.41 and a two-hundred day moving average of GBX 127.38. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39. The firm has a market cap of £102.20 million, a P/E ratio of -35.92 and a beta of 0.58.
Diaceutics Company Profile
(
Get Free Report)
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.
Recommended Stories
Before you consider Diaceutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diaceutics wasn't on the list.
While Diaceutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
